Effect of Progressive Relaxation Versus Isometric Exercises in Management of Primary Dysmenorrhea

Summary

This study will be conducted to compare the effect of progressive relaxation and isometric exercises in management of primary dysmenorrhea.

Conditions

• Primary Dysmenorrhea

Interventions

OTHER

Progressive Relaxation Exercises

Progressive relaxation exercises will be performed using controlled breathing combined with sequential muscle contraction and relaxation. Participants will be instructed to contract specific muscle groups during inspiration for 5-7 seconds, followed by relaxation during expiration for 15-20 seconds while focusing on the sensation of release. The sequence will include movements of the toes (flexion/extension, abduction/adduction), subtalar inversion/eversion, ankle dorsiflexion/plantarflexion, finger flexion/extension and abduction/adduction, as well as wrist flexion/extension and radial/ulnar deviation. This protocol will be carried out in a structured manner for approximately 25 minutes.

OTHER

Isometric Exercises

Participants will be instructed on the nature and correct performance of the exercises prior to the first session. The program will be performed 5 days per week, twice daily, with each session lasting 10 minutes for 12 weeks. Each session will consist of seven stages performed in a supine position, including pressing the feet together, crossing and pressing the legs, squeezing a pillow between the knees, pressing the lower back against the ground, and performing head and neck lifting and directional movements toward each thigh. Each contraction will be held for 5 seconds followed by relaxation.

BEHAVIORAL

Lifestyle modification advices

All groups will receive lifestyle modification advice, including reducing caffeine, salt, and animal fat intake, quitting smoking, practicing relaxation techniques, applying heat, using herbal remedies, avoiding cold foods and drinks, and wearing loose cotton clothing. Participants in groups A and B will also receive the same lifestyle modification guidance alongside their respective interventions.

Sponsors & Collaborators

• Cairo University

  lead OTHER

Principal Investigators

• Azza Barmoud Nashed Kassab, PhD · Professor, Cairo University

• Mai Mohamed Ali Shehata, PhD · Ass. Professor, Cairo University

• Mohamed Fawzy Abou Elenen, PhD · Consultant, Om El Masryeen

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

25 Years

Sex

FEMALE

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2024-11-11

Primary Completion

2025-07-04

Completion

2025-10-20

Countries

• Egypt

Study Locations